Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Immersion | IMMR | Sep 27, 2024 | 8.95 | +3.11 |
Immix Biopharma | IMMX | Sep 27, 2024 | 1.56 | -1.89 |
ImmuCell | ICCC | Sep 27, 2024 | 3.55 | -1.66 |
Immuneering A | IMRX | Sep 27, 2024 | 2.66 | +1.92 |
Immunic | IMUX | Sep 27, 2024 | 1.55 | +3.33 |
ImmunityBio | IBRX | Sep 27, 2024 | 3.93 | +0.77 |
Immunocore ADR | IMCR | Sep 27, 2024 | 31.40 | +2.05 |
Immunome | IMNM | Sep 27, 2024 | 14.38 | +0.28 |
ImmunoPrecise Antibodies | IPA | Sep 27, 2024 | 0.65 | -3.34 |
Immunovant | IMVT | Sep 27, 2024 | 28.02 | -1.02 |
Immutep ADR | IMMP | Sep 27, 2024 | 2.22 | -2.20 |
Imperial Oil | IMO | Sep 27, 2024 | 70.29 | +2.34 |
Imperial Petroleum | IMPP | Sep 27, 2024 | 4.00 | +1.27 |
Imperial Petroleum A Pref | IMPPP | Sep 27, 2024 | 25.40 | +0.00 |
Impinj | PI | Sep 27, 2024 | 213.31 | -2.08 |
Imunon | IMNN | Sep 27, 2024 | 1.04 | +2.97 |
IN8bio | INAB | Sep 27, 2024 | 0.29 | +0.28 |
Inari Medical | NARI | Sep 27, 2024 | 41.20 | +1.28 |
Incannex Healthcare ADR | IXHL | Sep 27, 2024 | 2.02 | -0.98 |
Inception Growth Acquisition | IGTA | Sep 27, 2024 | 11.32 | 0.00 |
Inception Growth Acquisition Unit | IGTAU | Sep 27, 2024 | 11.14 | 0.00 |
Income Opportunity Realty Investors | IOR | Sep 27, 2024 | 18.00 | 0.00 |
Incyte | INCY | Sep 27, 2024 | 65.83 | +1.07 |
Indaptus Therapeutics | INDP | Sep 27, 2024 | 1.30 | +22.64 |
Independence Realty Trust | IRT | Sep 27, 2024 | 20.49 | -0.15 |
Independent Bank | INDB | Sep 27, 2024 | 58.44 | -1.08 |
Independent Bank | IBCP | Sep 27, 2024 | 32.08 | -1.14 |
Independent Bank Group | IBTX | Sep 27, 2024 | 56.72 | +0.16 |
India Bull 3X Direxion | INDL | Sep 27, 2024 | 77.06 | -0.28 |
India Consumer Egshares | INCO | Sep 27, 2024 | 77.87 | -0.22 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.